Active, Not Recruiting
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
NCT00569127
- Conditions
- Colorectal Neuroendocrine Tumor G1, Gastric Neuroendocrine Tumor G1, Neoplasms, +8 more
- Locations
-
- Providence Hospital Mobile, Alabama, United States
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States